ASAN’s 2012 Warning on ABA Still Unheeded by Industry Leaders
Despite calls for autistic representation and ethical reforms, ABA clinics remain largely neurotypical in leadership roles, stalling meaningful change.
Opinion
Where the field argues with itself. Op-eds from BCBAs, founders, payers, attorneys, and self-advocates: the abolition-vs-reform debate, the 2026 payer reckoning, autistic representation in clinical leadership, and the right investors for a clinic. Bylines reflect their authors. Continues in private equity, policy, clinical practice.
The Abolition vs. Reform Debate in ABA: Can Applied Behavior Analysis Be Made Neurodiversity-Affirming, or Is That a Fundamental Contradiction?
The neurodiversity movement has split into two distinct critiques of ABA therapy. Reformists argue that ABA can evolve to center autistic perspectives, client assent, and quality of life while retaining its scientific…
2026: The Year ABA Must Prove Its Value or Watch Payers Prove It for Them
Industry insiders are warning that the ABA sector faces a reckoning in 2026 as payers of all types seek to control runaway spending. Reimbursement rates are declining, authorized hours are being cut,…
Why Every ABA Therapy Professional Needs to Be At the Autism Law Summit
The One Conference ABA Professionals Can't Afford to Miss.
The Wrong Type of Investor Will Destroy Your ABA Therapy Practice
ABA Therapy founders need to find right partner, or live with regret.